Cheuk Yan Chung

Ms. Cheuk Yan Chung

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Genes
Verified
Journal Article
Open access
PDF file
WJWenxuan Jiang
Wenxuan Jiang
RCRachel Yau Kar Cheung
Rachel Yau Kar Cheung
CCCheuk Yan Chung
Cheuk Yan Chung
SCSymphorosa Shing Chee Chan
Symphorosa Shing Chee Chan
KCKwong Wai Choy
Kwong Wai Choy
Background: Pelvic organ prolapse (POP) has become a common health problem among the aging population and affects an increasing number of elderly women worldwide. Studies within family and twin pairs provided strong evidence for the contribution of genetic factors to POP. Given the incomplete penetrance, polygenic traits, and small effect sizes of each variant in complex diseases, it is not always easy to evaluate the genetic susceptibility and molecular mechanisms involved in POP. Objectives: This review intends to comprehensively summarize the current studies on genetic variants associated with POP. Methods: We performed a comprehensive review to summarize the genetic findings from genome-linkage studies, genome-wide association studies, candidate association studies, and gene expression analyses. Results: We summarized genetic variants associated with connective tissue homeostasis, hormone metabolism, and oxidative stress, which were potentially related to the pathophysiology of POP. We also reviewed the limited polygenic risk score (PRS) studies generated for each individual’s genetic risk stratification and its integration into clinical risk factors for disease prediction. Conclusions: This pooled analysis provides moderate epidemiological credibility for associations of these genetic variants with POP to bridge the gap between genetic research and clinical medicine towards understanding the genetic etiology of POP. It also highlights the potential of PRS as a risk prediction model.

5 September 2023 in Human Genetics
Verified
Journal Article
Closed access
PDF file
CCCheuk Yan Chung
Cheuk Yan Chung
DPDora Jue Pan
Dora Jue Pan
Silvia ParacchiniSilvia Paracchini
Silvia Paracchini
WJWenxuan Jiang
Wenxuan Jiang
HSHon Cheong So
Hon Cheong So
KCKwong Wai Choy
Kwong Wai Choy

8 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
CCCheuk Yan Chung
Cheuk Yan Chung
DPDora Jue Pan
Dora Jue Pan
SPSilvia Paracchini
Silvia Paracchini
WJWenxuan Jiang
Wenxuan Jiang
HSHon-Cheong So
Hon-Cheong So
RCRichard Choy
Richard Choy
A recent genome-wide association study on dyslexia in 51,800 affected European adults and 1,087,070 controls detected 42 genome-wide significant SNPs. Among the 42 SNPs, rs2624839 further showed a significant association with quantitative reading fluency in a Chinese replication cohort. This study aimed at replicating the association between loci near the reported dyslexia associated rs2624839 and quantitative measurements of language and literacy in a unique cohort of bilingual Hong Kong Chinese twins who speak Chinese as first language and English as second language. To investigate the region near dyslexia associated rs2624839, proxy SNPs (rs1005678, rs12632110, and rs12494414) were tested at the population level (n = 308) and the within-twin level (n = 344, 172 twin pairs). At population level, significant associations with Chinese and English vocabulary knowledge were observed for all the three SNPs (p < .05). The strongest significant association after multiple testing correction was between rs12494414 and English vocabulary knowledge at the within-twin level (p = .004). We also demonstrated a trend of associations with English word reading and spelling, but larger sample size study is required to validate our findings. However, there was no significant associations with Chinese word reading and spelling. Our result suggests an important contribution of dyslexia-associated SNPs to language and literacy in Chinese and English in bilingual Chinese twins.

19 May 2026 in Human Reproduction Open
Verified
Journal Article
Open access
YLYing Li
Ying Li
MCMatthew Hoi Kin Chau
Matthew Hoi Kin Chau
YZYing Xin Zhang
Ying Xin Zhang
BGBaoheng Gui
Baoheng Gui
WLWai Ting Lui
Wai Ting Lui
KCKwong Wai Choy
Kwong Wai Choy
STUDY QUESTION: What is the incidence of triploidy and genome-wide uniparental disomy (gwUPD) in human embryos currently undetected by conventional preimplantation genetic testing (PGT)? SUMMARY ANSWER: Triploidy and gwUPD were detected in 0.8% (8/1049) and 1.4% (15/1049) of blastocysts, respectively. WHAT IS KNOWN ALREADY: Concurrent PGT enhances embryo selection by simultaneously detecting monogenic disorders (PGT-M) or structural rearrangements (PGT-SR) and aneuploidy (PGT-A). However, triploidy and gwUPD, two genome-wide abnormalities causative of severe pregnancy outcomes, are not routinely detected by conventional PGT platforms and thus remain under-recognized at the preimplantation stage. STUDY DESIGN, SIZE, DURATION: This study consisted of three phases: Phase I validated the detection capability of PGT-Plus on cell lines with previously ascertained genetic abnormalities; Phase II performed retrospective clinical validation on leftover trophectoderm biopsy whole-genome amplification (WGA) samples, including 65 for PGT-M, 67 for PGT-SR, and 130 for PGT-A received during January 2019 and July 2023; and Phase III was prospective implementation of PGT-Plus under a diagnostic setting on 529 blastocysts received from August 2023 to June 2024. Additionally, a cohort consisting of 258 embryo transfers, previously ascertained as euploid by conventional PGT-A methods but associated with unfavorable outcomes, was retested by PGT-Plus, which identified previously undetected cases of gwUPD or triploidy. PARTICIPANTS/MATERIALS, SETTING, METHODS: In Phase I, cell lines with ascertained genetic abnormalities were tested using at least one of the following methods, including G-banded Karyotyping, quantitative fluorescence PCR (QF-PCR), chromosomal microarray analysis (CMA), and mate-pair sequencing. The previous results were compared with those from PGT-Plus. In Phase II, results from conventional PGT platforms were compared in parallel with PGT-Plus to evaluate its accuracy. Cell lines or real trophoblast biopsy samples from blastocysts were amplified by the multiple displacement amplification (MDA) method. PGT-Plus data analysis was performed in various dimensions. For PGT-A analysis, except for canonical read-count analysis to assess the genome dosage, single nucleotide polymorphism (SNP) analysis was also performed to identify triploidy and gwUPD. Furthermore, for families requesting PGT-M and PGT-SR, linkage analysis was carried out for haplotype construction in addition to read-count analysis and SNP analysis. In addition to prospective cohort of Phase III, a unique cohort with adverse reproductive outcomes after transfer of a ‘euploid’ embryo, as determined by conventional PGT-A platforms, was retested to identify any triploidy and UPD among these copy-number neutral embryos. The unfavorable outcomes included no pregnancy, biochemical pregnancy, miscarriage, and termination of pregnancy due to fetal anomaly. MAIN RESULTS AND THE ROLE OF CHANCE: PGT-Plus detected all abnormalities ascertained by prior platforms in Phases I and II. In total, triploidy and gwUPD were detected in 0.8% (8/1049) and 1.4% (15/1049) of blastocysts, respectively. Notably, 3.5% (9/258) of the unfavorable transfers of embryos previously classified as ‘euploid’ would have been prevented if triploidy and gwUPD were detected. In addition, 45.7% (12/35) of embryos previously classified as balanced by PGT-SR were translocation carriers. LIMITATIONS, REASONS FOR CAUTION: PGT-Plus, similar to other relative phasing methods, requires an additional family member for haplotype determination, although an embryo with a known genotype via prior independent testing is also acceptable. In addition, short-read next-generation sequencing (NGS) impedes the capacity of PGT-Plus to directly detect pathogenic SNVs located in highly repetitive regions of the genome, e.g. the HBA1 gene causative of thalassemia, which still require conventional methods, including short tandem repeats and PCR, to safeguard clinical diagnosis or can be addressed by long-read sequencing. WIDER IMPLICATIONS OF THE FINDINGS: This newly established PGT-Plus approach additionally detected gwUPD and triploidy in preimplantation embryos. It explained another 3.5% of ‘euploid’ embryo transfer failures. Meanwhile, embryo selection was enhanced by integrating PGT-M, PGT-SR, or PGT-A with an analysis of parental origin and stage of non-disjunction within a single PGT-Plus workflow. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by the Research Grant Council Collaborative Research Fund (grant no. C4062-21GF to K.W.C.), the National Natural Science Foundation of China (grant no. 82502033 to Y.L.), and the Research Grant Council General Research Fund (grant no. 14100822 to J.P.W.C.). All authors declare that they have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

3 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
YZYU ZHENG
YU ZHENG
MSMengmeng SHI
Mengmeng SHI
YZYilin Zhao
Yilin Zhao
CCCheuk Yan Chung
Cheuk Yan Chung
MCMatthew Hoi Kin Chau
Matthew Hoi Kin Chau
YCYe Cao
Ye Cao
Background/Objectives: Recessive titinopathies caused by biallelic TTN truncating variants (TTNtvs) present a clinically heterogeneous spectrum from fetal demise to late-onset slowly progressive distal muscular dystrophy. Prognostic counseling is challenging due to the vast size of the TTN gene, complex splicing patterns, and differential expression throughout developmental stages and tissues. This paper aims to delineate the regional genotype patterns and clinical characteristics of recessive titinopathies described from the prenatal period onwards to inform genotype–phenotype associations and genetic counseling. Methods: We analyzed clinical and genetic data from a prenatal-onset cohort with biallelic TTNtvs from both previously reported cases and novel cases from our center. To characterize the regional distribution of biallelic variants within this specific cohort, a two-dimensional scatter plot was utilized to map variants onto 10 biological regions (R1–R10) and 55 analytical units (U1–U55). We also performed Fisher’s exact tests on the subset of 50 cases with confirmed survival records to evaluate statistically significant associations between biallelic regional or percent spliced-in (PSI) thresholds combinations and severe clinical endpoints (intrauterine demise or death before 5 years). Results: A total of 96 prenatal cases from 76 unrelated families were analyzed. Decreased fetal movement was the most commonly reported symptom, observed in 81.3% (78/96) of cases, which was followed by arthrogryposis in 45.8% (44/96) and amniotic fluid volume abnormalities in 35.4% (34/96). Additionally, of the 95 cases with known pregnancy outcomes, 25.3% (24/95) resulted in termination and 11.6% (11/95) resulted in intrauterine demise (IUD), while 63.2% (60/95) reached birth with over 16.7% (10/60) being preterm. Among 60 live-born infants, severe postnatal morbidity was high: 45.0% (27/60) experienced respiratory failure, and 33.3% (20/60) died before the age of five. In this cohort, 84.4% (81/96) of cases possessed at least one TTNtv in either the metatranscript-only or A-band regions. The most common biallelic changes involved TTNtvs in both the A-band and metatranscript-only regions, accounting for 35.4% (34/96) of cases, followed by metatranscript-only combined with I-band variants at 16.7% (16/96), regardless of the PSI score of exons. Overall, 83.3% (80/96) had ≥1 variant on low-PSI (90%) exons were significantly associated with severe outcomes (intrauterine demise or death before 5 years; exact p = 0.015), whereas the metatranscript-only plus I-band combination conferred a significantly lower risk of lethality before 5 years of age (exact p = 0.001). Conclusions: Our findings add to the accumulating evidence that TTNtvs on low PSl exons or metatranscript-only regions are frequently observed among reported prenatal-onset recessive titinopathy. Health surveillance for heterozygous carriers among family members is warranted due to the substantial risk for adult-onset dilated cardiomyopathy and peripartum cardiomyopathy.